REPLIVAX Trademark

Trademark Overview


On Thursday, July 30, 1992, a trademark application was filed for REPLIVAX with the United States Patent and Trademark Office. The USPTO has given the REPLIVAX trademark a serial number of 74299563. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, October 1, 1994. This trademark is owned by Repligen Corporation. The REPLIVAX trademark is filed in the Pharmaceutical Products category with the following description:

HIV vaccine for human use

General Information


Serial Number74299563
Word MarkREPLIVAX
Filing DateThursday, July 30, 1992
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, October 1, 1994
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 5, 1993

Trademark Statements


Goods and ServicesHIV vaccine for human use
Pseudo MarkREPLIGEN VACCINE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRepligen Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameRepligen Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Saturday, October 1, 1994ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 9, 1994EXTENSION 2 GRANTED
Wednesday, March 30, 1994EXTENSION 2 FILED
Wednesday, November 17, 1993EXTENSION 1 GRANTED
Thursday, September 23, 1993EXTENSION 1 FILED
Tuesday, March 30, 1993NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 1993PUBLISHED FOR OPPOSITION
Friday, December 4, 1992NOTICE OF PUBLICATION
Thursday, October 15, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 23, 1992ASSIGNED TO EXAMINER

Related Keywords


replivax human vaccine